So happy to be part of this study supporting Veterans' Health - Harm Reduction Vending Machines in Supportive Housing for Veterans jamanetwork.com/journals/jam…
35
Michael Douglas retweeted
Proud of this teamwork! @Rayliukpsfo @CBMHCare @cebweldon @LoriSakoda @BroosBruce @JVelottaMD @jmsuga @PermanenteDocs @aboutKP @genentech
‼️ #ASCO26 simultaneous publication by Trosman et al:
Optimizing Cancer Care Delivery Through High-Functioning Teams: Results of Implementing the 4R Oncology Model in Lung and Breast Cancer
Read the full article: bit.ly/4v6hwoa
#lcsm #bcsm
Michael Douglas retweeted
Read the latest TRANSPERS news: Phillips joins MEDPAC, Mrig named Emerging Scholar, new publications, and more conta.cc/3KNzsTg
Michael Douglas retweeted
Read the latest TRANSPERS news on Cost-Effectiveness and Equity, Awards, Arctic Adventures, and more conta.cc/3H95Pty
Our new research review maps the decision-making journey for upper limb prosthetic users. Key factors influencing choices include functionality, appearance, weight, and cost. sciencedirect.com/science/ar…
36
Michael Douglas retweeted
Read the latest TRANSPERS news on Payer Decision-Making, Patient-Centered Genomics, and more conta.cc/4cRXl5x
US payers, providers & stakeholders see payer role in genomic testing implementation as feasible. Findings inform broad healthcare efforts & precision oncology professionals shaping policy. pubmed.ncbi.nlm.nih.gov/4002…
34
🔍 Research participants needed! Help us understand eye allergy treatment choices (no eye allergies required!)
Anonymous survey
10-15 mins
Must be 18+
Voluntary participation
Your input will help improve eye allergy care!
Survey Link: eyeallergysurvey5.sawtoothso…
1
71
You can now find me on Bluesky at @michaeldouglasms.bsky.social. Future posts will appear there.
35
Catch the latest from TRANSPERS.
Read the latest TRANSPERS news on recent JAMA Network publications, a new award, and a fun fact conta.cc/3Af6qqf
44
Looking for a Postdoc Position? Seeking a highly motivated scientist in biostatistical analysis and discrete choice measurement for healthcare and treatment-related outcomes and health economics. Join the Wilson Lab @UCSF, @ucsfpharmacy. More Info. opportunities.ucsf.edu/conte…
1
4
227
Join Dr. Oni-Orisan's @UCSF team as a postdoc in biostatistics, pharmacogenomics, cardiology & precision medicine. Email CV & research interests to [email protected] @akinyemi_OO @IHG_at_UCSF More information: opportunities.ucsf.edu/conte…
Michael Douglas retweeted
Congratulations to Dept. of Clinical Pharmacy faculty member @Akinyemi_OO, PharmD, PhD, who has been named a 2023 Emerging Leader in Health and Medicine Scholar by the @theNAMedicine, expanding his work in precision medicine and cardiovascular disease. tiny.ucsf.edu/MJrxxV
Searching for a Postdoc Position? Seeking a highly motivated scientist in biostatistical analysis and discrete choice measurement for healthcare and treatment-related outcomes and health economics. Join the Wilson Lab @UCSF, @ucsfpharmacy. More Info. opportunities.ucsf.edu/conte…
177
Do you have an interest in Healthcare and Data Science? We are looking for a Data Analyst to join our team in the Wilson Lab @UCSF, @ucsfpharmacy. More information. sjobs.brassring.com/TGnewUI/…
1
96
Join @Akinyemi_OO's dynamic lab at UCSF! Seeking a highly motivated intern/fellow with a passion for #precisionmedicine, #pharmacogenomics, and #cardiology. Analyze large datasets & gain research experience. Apply now: [email protected] #Internship ucsf.labspot.io/opportunity?…
This opportunity is open to UCSF and non-UCSF students at both graduate and undergraduate levels. @UCSFPrecision @IHG_at_UCSF @UCSFMedicine, @UCSFEpiBiostats @UCBIDS @BerkeleyDataSci @WiDSBerkeley @usfca_msds @DataInstituteSF
104
Michael Douglas retweeted
Thank you @KathrynP_phd @MDouglas_MS @cebweldon @MaryPasquinelli @sheetalkircher @AllisonKurian, Nikki Martin. Newly published paper on payers; coverage for #liquidbiopsy tests for #cancer #screening @Health_Affairs #HAScholar. academic.oup.com/healthaffai…
Our new paper reveals US payers’ barriers, opportunities for coverage of MCED, promising but controversial tests for multicancer early detection @Health_Affairs #HAScholar @KathrynP_phd @AllisonKurian @cebweldon Nikki Martin academic.oup.com/healthaffai…
An accompanying commentary from @dr_msocal
highlights important points re #Medicare coverage and #lab_benefit_managers jnccn.org/view/journals/jncc…
Replying to @UCSF_TRANSPERS
@UCSF_TRANSPERS JNCCN study highlights the importance of ctDNA testing coverage for effective cancer care, with variable coverage across payers, clinical indications, and cancer types to ensure access to initial targeted therapy and therapeutic resistance. jnccn.org/view/journals/jncc…












